Neuronal signal substances as biomarkers of migraine

Headache

Volumn 46, Issue 7, 2006, Pages 1088-1094

  Edvinsson, Lars ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Neuronal signal substances; Primary headaches

Indexed keywords

BIBN 4096; BIOLOGICAL MARKER; BOSENTAN; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONIST; ENDOTHELIN; ENDOTHELIN RECEPTOR; INDOMETACIN; N(G) NITROARGININE; NEUROPEPTIDE; NITRIC OXIDE; OLCEGEPANT; SUMATRIPTAN; TRIPTAN DERIVATIVE;

CHRONIC PAROXYSMAL HEMICRANIA; HUMAN; MIGRAINE; PAIN ASSESSMENT; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PROTEIN SECRETION; RELIABILITY; REVIEW; SENSORY NERVE;

BIOLOGICAL MARKERS; CALCITONIN GENE-RELATED PEPTIDE; CLUSTER HEADACHE; ENDORPHINS; HUMANS; MIGRAINE DISORDERS; NEURONS, AFFERENT; NEUROPEPTIDES; NITRIC OXIDE; NITROUS OXIDE;

EID: 33745611399     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2006.00502.x     Document Type: Review

References (38)

1. Holfhusen H, Kindgen-Milles D, Ding ZP. Substance P is not involved in vascular nociception in humans. Neuropeptides. 1997;31:445-448.
2. Gulbenkian S, Uddman R, Edvinsson L. Neuronal messengers in the human cerebral circulation. Peptides. 2001;22:995-1007.
3. Edvinsson L, Uddman R. Neurobiology in primary headaches. Brain Res Rev. 2005;48:438-456.
4. Pietrobon D, Striessnig J. Neurobiology of migraine. Nat Rev Neurosci. 2003;4:386-398.
5. Mosnaim AD, Chevesich J, Wolf ME, Callaghan OH, Diamond S. Plasma methionine enkephalin levels. A biological marker for migraine? Headache. 1985;25:259-261.
6. Mosnaim AD, Chevesich J, Wolf ME, et al. Plasma methionine enkephalin. Increased levels during a migraine episode. Headache. 1986a;26:278-281.
7. Ferrari MD, Frölich M, Odink J, Tapparelli C, Portielje JEA, Bruyn GW. Methionine-enkephalin and serotonin in migraine and tension headache. In:Clifford RF ed. Advances in Headache Research. London: John Libbey; 1987:227-234.
8. Bach FW, Jensen K, Blegvad N, Fenger M, Jordal R, Olesen J. β-Endorphin and ACTH in plasma during attacks of common and classic migraine. Cephalalgia. 1985;5:177-182.
9. 5) - enkephalin-, substance P- and somatostatin-like immunoreactivities in painful and pain-less human diseases. In:Sicuteri F, Vecchiet L, Fanciullacci M, eds. Trends in Cluster Headache. Amsterdam: Excerpta Medica; 1987:135-143.
10. Blegvad N, Jensen K, Fahrenkrug J, Schaffalitzky de Muckadell OB,Olesen J. Plasma-VIP and substance-P during migraine-attack. Cephalalgia. 1986a;5(suppl.2):352-353.
11. Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol. 1990:28:183-187.
12. Blegvad N, Jensen K, Soelberg Sørensen P, Hammer M, Olesen J. Plasma-vasopression during migraine-attack. Cephalalgia. 1986b;5(suppl.2):350- 351.
13. Anselmi B, Baldi E, Casacci F, Salmon S. Endogenous opioids in cerebrospinal fluid and blood in idiopathic headache sufferers. Headache. 1980;20:294-299.
14. Hardebo JE, Ekman R. Substance P and opioids in cluster headache. In: Sicuteri F, Vecchiet L, Fanciullacci M, eds. Trends in Cluster Headache. Amsterdam: Excerpta Medica; 1987:145-158.
15. Sicuteri F, Fanciullacci M, Geppetti P, Renzi D, Caleri D, Spillantini MG. Substance P mechanisms in cluster headache: Evaluation in plasma and cerebrospinal fluid. Cephalalgia. 1985;5:143-149.
16. Appenzeller O, Atkinson RA, Standefer JC. Serum β-endorphin in cluster headache and common migraine. In: Clifford Rose F, Zilkha K, eds. Progress in Migraine Research, Vol. 1. Bath: Pitman; 1981:106-109.
17. Goadsby PJ, Edvinsson L, Ekman R. Release of vasocactive peptides in the extracerebral circulation of humans and the cat during activation of the trigemino-vascular system. Ann Neurol. 1988;193-196.
18. Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: Studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol. 1993;33:48-56.
19. Gallai V, Floridi A, Mazzotta G, et al. L-arginine/nitric oxide pathway activation in platelets of migraine patients with and without aura. Acta Neurol Scand. 1996;94:151-160.
20. Juhasz G, Zsombok T, Modos EA, et al. NO-induced migraine attack: Strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release. Pain. 2003;461-470.
21. Juhasz G, Zsombok T, Jakab B, Nemeth J, Szolcsanyi J, Bagdy G. Sumatriptan causes parallel decrease in plasma calcitonin gene-related peptide (CGRP) concentration and migraine headache during nitroglycerin induced migraine attack. Cephalalgia. 2005;25:179-183.
22. Hou M, Kanje M, Longmore J, Tajti J, Uddman R, Edvinsson L. 5-HT1B and 5-HT1D receptors in the human trigeminal ganglion: Co-localization with calcitonin gene-related peptide, substance P and nitric oxide synthase. Brain Res. 2001;909:112-120.
23. Smith D, Hill RG, et al. An immunocytochemical investigation HT1D-receptor immunoreactivities are expressed by trigeminal sensory fibres. Cephalalgia. 2002;22:424-431.
24. Durhan PL, Russo AF. Regulation of calcitonin gene-related peptide secretion by a serotonergic antimigraine drug. J Neurosci. 1999;19:3423-3429.
25. Olesen J, Diener HC, et al. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med. 2004;350:1104-1110.
26. Goadsby PJ, Edvinsson L. Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute therapies. Brain. 1994;117:427-434.
27. Fanciullaci M, Alessandri M, et al. Increase in plasma calcitonin gene-related peptide from the extracerebral circulation during nitroglycerin-induced cluster headache attack. Pain. 1995;60:119-123.
28. Fanciullaci M, Alessandri M, et al. Responsiveness of the trigeminovascular system to nitroglycerine in cluster headache patients. Brain. 1997;120:283-288.
29. Goadsby PJ, Edvinsson L, Ekman R. Cutaneous sensory stimulation leading to facial flushing and release of calcitonin gene-related peptide. Cephalalgia. 1992;12:53-56.
30. Goadsby PJ, Edvinsson L. Neuropeptide changes in a case of chronic paroxysmal hemicrania - evidence for trigemino-parasympathetic activation. Cephalalgia. 1996;16:448-450.
31. Färkkilä M, Palo J, Saijonmaa O, et al. Raised plasma endothelin during acute migraine attack. Cephalalgia. 1992;12:383-384.
32. May A, Gijsman HJ, Wallnofer A, Jones R, Diener HC, Ferrari MD. Endothelin antagonist bosentan blocks neurogenic inflammation, but is not effective in aborting migraine attacks. Pain. 1996;67:375-378.
33. Olesen J, Thomsen LL, Lassen LH, Olesen IJ. The nitric oxide hypothesis of migraine and other vascular headaches. Cephalalgia. 1995;94-100.
34. Sarchielli P, Alberti A, Codini M, et al. Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks. Cephalalgia. 2000;20:907-918.
35. Gallai V, Sarchielli P, et al. Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally. Cephalalgia. 1995;15:384-390.
36. Lassen LH, Ashina M, Christiansen I, Ulrich V, Olesen J. Ntric oxide synthase inhibition in migraine. Lancet. 1997;349:401-402.
37. Tajti J, Uddman R, Moller S, Sundler F, Edvinsson L. Messenger molecules and receptor mRNA in the human trigeminal ganglion. J Auton Nerv Syst. 1999;76:176-183.
38. Jansen-Olesen I, Zhou M, Zinck T, Xu CB, Edvinsson L. Expression of inducible nitric oxide synthase in trigeminal ganglion cells during culture. Basic Clin Pharmacol Toxicol. 2005;97:355-363.